PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Enterprise Value (2022 - 2026)

PepGen (PEPG) posted Enterprise Value of -$132.3 million for Q1 2026, up 10.88% sequentially from -$148.5 million in Q4 2025, and down 35.31% YoY from -$204.5 million in Q1 2025.

Analysis

PepGen (PEPG) Enterprise Value (2022 - 2026) Analysis & Trends

PepGen has reported Enterprise Value for 6 years, with the latest figure at -$132.3 million in Q1 2026.

  • Quarterly Enterprise Value fell 35.31% year-over-year to -$132.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$132.3 million (down 35.31% YoY) and the FY2025 annual result came in at -$148.5 million, down 23.52% from the prior year.
  • Enterprise Value advanced to -$132.3 million in Q1 2026 per PEPG's latest filing, from -$148.5 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$74.7 million in Q2 2025 and troughed at -$218.8 million in Q2 2022.
  • A 5-year average of -$145.9 million and a median of -$147.0 million in 2023 frame the typical range for Enterprise Value.
  • The sharpest annual moves came in 2022 and 2025: Enterprise Value slumped 1682.72% in 2022, then soared 53.72% in 2025.
  • Over 5 years, Enterprise Value stood at -$181.8 million in 2022, then surged by 39.25% to -$110.4 million in 2023, then retreated by 8.86% to -$120.2 million in 2024, then fell by 23.52% to -$148.5 million in 2025, then increased by 10.88% to -$132.3 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$132.3 million, -$148.5 million, and -$163.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 PepGen 217.99 Mn 217.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.43 Mn
Mar 31, 2026 -9.87 Mn
Dec 31, 2025 126.41 Mn
Sep 30, 2025 -4.91 Mn
Jun 30, 2025 -38.25 Mn
Mar 31, 2025 -51.97 Mn
Dec 31, 2024 3.44 Mn
Sep 30, 2024 139.84 Mn
Jun 30, 2024 358.83 Mn
Mar 31, 2024 301.31 Mn
Dec 31, 2023 51.59 Mn
Sep 30, 2023 -8.57 Mn
Jun 30, 2023 65.87 Mn
Mar 31, 2023 125.45 Mn
Dec 31, 2022 27.35 Mn
Sep 30, 2022 18.79 Mn
Jun 30, 2022 -78.90 Mn